However, compared to MDV/RB1B infection, MDV/CVI988 infection resulted in a more effective transcriptional activation of CCL4 in the latent infection phase (7–14 dpi), which may be a characteristic distinguishing the vaccine MDV strain from the vvMDV strain. Here, CCL4 is linked to disease arising from reactivation of latent virus.